Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Use & Safety Information</h2>
<div class="info-card warning">
<p><strong>High-concentration injectable:</strong> Enantat 400 contains Testosterone Enanthate at 400 mg/mL. Higher-concentration oil-based formulations can produce more noticeable post-injection discomfort than lower-strength preparations.</p>
</div>
<h3>Administration Profile</h3>
<ul class="usage-highlights">
<li>✔ Oil-based injectable formulation</li>
<li>✔ Long-acting testosterone enanthate ester</li>
<li>✔ High concentration of 400 mg/mL</li>
</ul>
<p>Testosterone Enanthate is designed for prolonged release after intramuscular administration. Because Enantat 400 contains considerably more active substance per milliliter than common 200–250 mg/mL preparations, concentration and injection-site tolerability are important considerations.</p>
<h3>High-Concentration Formulation & PIP</h3>
<p>Increasing the amount of active substance dissolved in each milliliter can influence how an injectable formulation feels after administration. Individual response varies, but high-concentration oil-based products may produce increased soreness, tenderness, swelling, or post-injection pain.</p>
<p>Persistent or severe pain, increasing redness, unusual warmth, significant swelling, fever, discharge, or other concerning symptoms should not automatically be assumed to be normal PIP and should be medically evaluated.</p>
<h3>Estrogen & Hormonal Considerations</h3>
<p>Testosterone can convert to estrogen through the aromatase enzyme. Products commonly associated with estrogen management include <a href="/anti-estrogens-393/arimidex-2987">Arimidex</a> and other <a href="/aromatase-inhibitors-3852">aromatase inhibitors</a>. Their use should be based on individual need, symptoms, and appropriate laboratory monitoring rather than assumed to be necessary for every user.</p>
<h3>Post-Cycle Considerations</h3>
<p>Exogenous testosterone can suppress natural testosterone production. Products commonly researched in the context of post-cycle recovery include <a href="/anti-estrogens-393/nolvadex-2998">Nolvadex</a>, <a href="/anti-estrogens-393/clomid-2989">Clomid</a>, and <a href="/buy-2194/hcg-5000-iu-40775">HCG</a>. Additional options are available in the <a href="/post-cycle-therapy-3855">Post-Cycle Therapy category</a>.</p>
<p>Recovery requirements can vary considerably depending on prior hormone exposure, duration of use, individual physiology, and laboratory values. Medical evaluation and bloodwork provide more useful information than relying on a fixed one-size-fits-all protocol.</p>
<h3>Related Compounds</h3>
<p>Testosterone Enanthate is frequently discussed alongside injectable compounds such as <a href="/injectables-391/eq-2916">EQ 300</a> and <a href="/injectables-391/trenbolone-2924">Trenbolone 200</a>, as well as oral compounds such as <a href="/orals-380/winstrol-2816">Winstrol</a>. These products differ substantially in their pharmacology, adverse-effect profile, and monitoring considerations.</p>
<h3>Important Health Considerations</h3>
<ul>
<li>Testosterone can suppress endogenous testosterone production</li>
<li>Estrogen-related effects can occur through aromatization</li>
<li>Blood pressure may increase</li>
<li>Hematocrit and hemoglobin can rise</li>
<li>Cholesterol and lipid markers can be adversely affected</li>
<li>Androgenic effects such as acne and changes in hair growth can occur</li>
<li>Cardiovascular risk can be affected by dose, duration, health status, and concurrent substances</li>
</ul>
<div class="info-card">
<p><strong>Important:</strong> Laboratory confirmation of concentration verifies the tested sample but does not establish that unsupervised testosterone use is safe. Appropriate medical evaluation and laboratory monitoring are important when testosterone is used therapeutically.</p>
</div>
</section>
</div>
Product Details
Active Substance
Testosterone Enanthate
Ester Type
Enanthate (long-acting ester)
Formulation
Oil-Based Injectable
Total Labeled Content
4,000 mg per vial
Latest Verified Assay
400.08 mg/mL
Latest Tested Batch
TEHD6
Manufacturer
Dragon Pharma
Availability
USA Domestic & International